Pharmaceutical Industry news

• Monthly News Roundup - November 2023

  30-11-2023 01:11 via drugs.com
  FDA Approves Lilly’s Zepbound for Chronic Weight Management
  In November, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide), a glucose-dependent insulinotropic polypeptide (GIP) and ...
  
  Read more

• Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults

  29-11-2023 13:38 via pmlive.com
  RSV is associated with 15,000 hospital admissions in infants under six months every year in England
  
  Read more

• Novo Nordisk announces $2.3bn investment to expand production site in France

  24-11-2023 13:34 via pmlive.com
  The investment will significantly increase the manufacturing capacity for the company’s GLP-1 products
  
  Read more

• 23rd PMEA celebrate excellence in pharmaceutical marketing

  23-11-2023 13:29 via pmlive.com
  This year’s Awards were held at the Sheraton Park Lane in London and included 14 categories
  
  Read more

• Advertisement

• Whole Grain Consumption Linked to Slower Global Cognitive Decline

  22-11-2023 23:11 via drugs.com
  WEDNESDAY, Nov. 22, 2023 -- Higher consumption of whole grains is associated with a slower rate of global cognitive decline, according to a study published online Nov. 22 in Neurology.
  Xiaoran Liu, Ph.D., from Rush University Medical Center in...
  
  Read more

• >10 Percent of FIT Are Unsatisfactory and Cannot Be Processed

  22-11-2023 23:11 via drugs.com
  WEDNESDAY, Nov. 22, 2023 -- More than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15 months, according to a study published online...
  
  Read more

• Mobile Apps Effective for Treating Moderate and Severe Depression

  21-11-2023 17:48 via drugs.com
  TUESDAY, Nov. 21, 2023-- Mobile app interventions are effective for treating moderate and severe depression, according to a review published online Nov. 20 in JAMA Network Open.Hayoung Bae, from Korea University in Seoul, and colleagues...
  
  Read more

• Pfizer and Astellas’ Xtandi approved by FDA for earlier prostate cancer indication

  20-11-2023 13:30 via pmlive.com
  Xtandi is now the first androgen receptor signalling inhibitor approved for use in this patient population
  
  Read more

• Advertisement

• Short Sleep Duration Impairs Insulin Sensitivity in Women

  17-11-2023 23:11 via drugs.com
  FRIDAY, Nov. 17, 2023-- Short sleep duration for six weeks impairs insulin sensitivity in women, according to a study published online Nov. 15 in Diabetes Care.Faris M. Zuraikat, Ph.D., from the Columbia University Irving Medical Center in New...
  
  Read more

• AstraZeneca’s Truqap plus Faslodex receives FDA approval for advanced breast cancer

  17-11-2023 13:21 via pmlive.com
  More than 290,000 people in the US are expected to be diagnosed with breast cancer in 2023
  
  Read more

• Opioid Rx Down, but Overdoses and Deaths Up, AMA Report Shows

  16-11-2023 00:11 via drugs.com
  WEDNESDAY, Nov. 15, 2023 -- Opioid prescribing by physicians and other health professionals has decreased for the 13th consecutive year, down nearly 50 percent since 2012, while overdoses and deaths related to illicitly manufactured fentanyl,...
  
  Read more

• Almirall and Absci announce $650m AI drug discovery partnership for dermatological diseases

  14-11-2023 13:20 via pmlive.com
  The collaboration marks an expansion to Absci’s de novo AI drug creation portfolio into dermatology
  
  Read more

• AHA: Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes

  14-11-2023 01:11 via drugs.com
  MONDAY, Nov. 13, 2023 -- Weekly subcutaneous semaglutide significantly cuts the incidence of cardiovascular death and nonfatal heart attacks and strokes in adults with preexisting cardiovascular disease and overweight or obesity but no diabetes,...
  
  Read more

• Valneva’s chikungunya vaccine approved by FDA for adults at increased exposure risk

  10-11-2023 13:14 via pmlive.com
  
  The decision makes Ixchiq, which is administered as a single injection, the world's first licensed vaccine against the mosquito-borne disease
  
  Read more

• Takeda’s Fruzaqla receives FDA approval for metastatic colorectal cancer

  10-11-2023 13:14 via pmlive.com
  
  More than 150,000 new cases of colorectal cancer will be diagnosed in the US in 2023
  
  Read more

• NICE recommends Chiesi’s alpha-mannosidosis enzyme replacement therapy

  10-11-2023 13:13 via pmlive.com
  
  Alpha-mannosidosis, an extremely rare inherited condition characterised by a broad range of impairments, affects approximately 25 people in England
  
  Read more

• New £5m project launched to bring Alzheimer’s blood tests to the NHS

  10-11-2023 13:13 via pmlive.com
  
  Blood tests for the condition could become available on the NHS within five years
  
  Read more

• UK antibiotic subscription model found by OHE as key to supporting investment

  10-11-2023 13:12 via pmlive.com
  
  The OHE report offers valuable insights into investor views of the subscription model
  
  Read more

• Opioid Use Down With Erector Spinae Plane Blocks in Lumbar Laminectomy

  10-11-2023 01:00 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- For patients undergoing open lumbar laminectomy, ultrasound-guided bilateral erector spinae plane blocks (ESPBs) combined with multimodal analgesia reduce opioid consumption, according to a study recently published in the...
  
  Read more

• Earlier Onset of A-Fib Linked to Risk of Developing All-Cause Dementia

  10-11-2023 01:00 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- Earlier onset of atrial fibrillation (AF) is associated with increased risk of developing all-cause dementia, vascular dementia (VD), and Alzheimer disease (AD), according to a study published online Nov. 8 in JAMA Network...
  
  Read more

• Considerable Shortages of Minoxidil Recorded in Greater D.C. Area

  10-11-2023 01:00 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- There are considerable shortages of oral minoxidil 2.5 mg and 10 mg tablets, used for treatment of androgenetic alopecia, within the District of Columbia, Maryland, and Northern Virginia (DMV) area, according to a research...
  
  Read more

• Caregiving Linked to Lower Mortality in Postmenopausal Women

  10-11-2023 01:00 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- Caregiving is associated with lower mortality among postmenopausal women, according to a study published online Nov. 8 in the Journal of the American Geriatrics Society.Prachi P. Chavan, Ph.D., from the University at...
  
  Read more

• Man Maimed by Electric Shock Receives First-Ever Face Transplant That Includes New Eye

  10-11-2023 00:17 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- An Arkansas man maimed by a massive electrical shock to his face has successfully received the world's first whole-eye and partial face transplant.In a 21-hour surgery performed in May, Eduardo Rodriguez, M.D., director of...
  
  Read more

• First-Ever Face Transplant That Includes New Eye For Man Maimed by Shock

  10-11-2023 00:11 via drugs.com
  
  THURSDAY, Nov. 9, 2023 -- An Arkansas man maimed by a massive electrical shock to his face has successfully received the world's first whole-eye and partial face transplant.
  In a 21-hour surgery performed in May, Eduardo Rodriguez, M.D., director...
  
  Read more

• Botulinum Toxin May Be Beneficial for Isolated, Essential Head Tremor

  09-11-2023 18:00 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- For patients with isolated or essential head tremor, injection of botulinum toxin into each splenius capitis muscle on day 0 and during week 12 is more effective than placebo for reducing tremor severity, according to a...
  
  Read more

• AAO: Research Highlights Vision Issues Seen in Pediatric Sickle Cell Disease

  09-11-2023 17:38 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- For pediatric patients with sickle cell disease (SCD), ophthalmologic complications include nonproliferative retinopathy (NPR) and proliferative retinopathy (PR), which occur in 33 and 6 percent, respectively, according to...
  
  Read more

• AAO: Diabetic Retinopathy Usually No Worse With Semaglutide in T2D

  09-11-2023 17:35 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the American Academy of...
  
  Read more

• Concurrent RNA and DNA Sequencing Improves Variant Detection

  09-11-2023 17:33 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- Performing RNA sequencing concurrently with DNA sequencing improves detection of novel variants and classification of existing variants, according to a study published online Nov. 4 in JAMA Oncology to coincide with the...
  
  Read more

• Eating Disorders Linked to Negative Physical Health

  09-11-2023 17:14 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- Eating disorders are associated with a significant increase in the risk for physical multimorbidity, according to a study recently published online in Eating and Weight Disorders.Lee Smith, from Anglia Ruskin...
  
  Read more

• Yoga Intervention Can Reduce Felt Stigma in Epilepsy Patients

  09-11-2023 17:11 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- For patients with epilepsy, yoga therapy plus psychoeducation can reduce felt stigma, according to a study published online Nov. 8 in Neurology.Kirandeep Kaur, Ph.D., from the All India Institute of Medical Sciences in New...
  
  Read more

• FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

  09-11-2023 17:08 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active...
  
  Read more

• Coadministration of COVID-19, Influenza Vaccines Seems Effective

  09-11-2023 17:02 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- Coadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and seasonal influenza vaccine (SIV) generally has similar effectiveness against COVID-19- and SIV-related outcomes compared with...
  
  Read more

• 2023 Guidelines Update Eligibility for Lung Cancer Screening

  09-11-2023 16:58 via drugs.com
  
  THURSDAY, Nov. 9, 2023-- In a guideline update issued by the American Cancer Society and published online Nov. 1 in CA: A Cancer Journal for Clinicians, the authors recommend increasing eligibility for lung cancer screening (LCS).Andrew M.D. Wolf,...
  
  Read more

• AstraZeneca gains rights to Eccogene’s cardiometabolic disease drug in deal worth over $1.8bn

  09-11-2023 13:38 via pmlive.com
  
  The oral candidate could offer more dosing convenience over current injectable therapies
  
  Read more

• Researchers improve understanding of COVID-19 virus and future variants

  09-11-2023 13:37 via pmlive.com
  
  The study aims to contribute to the design of future COVID-19 vaccines and drugs
  
  Read more

• Eli Lilly’s tirzepatide injection approved by MHRA and FDA for weight loss in adults

  09-11-2023 13:37 via pmlive.com
  
  The drug has been authorised for use alongside a reduced-calorie diet and physical activity
  
  Read more

• Spinal stimulation implant offers new hope for Parkinson’s disease treatment

  09-11-2023 13:36 via pmlive.com
  
  The implant was tested to correct gait disorders associated with advanced cases of the disease
  
  Read more

• Janssen reports positive real-world data for Tremfya in psoriatic arthritis

  09-11-2023 13:36 via pmlive.com
  
  The IL-23 inhibitor holds approvals to treat certain psoriatic arthritis and plaque psoriasis patients
  
  Read more

• One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD

  09-11-2023 01:00 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- For individuals with opioid use disorder (OUD) using fentanyl, a one-day induction of extended‐release buprenorphine is a feasible treatment approach, according to a study published online Nov. 8 in the American Journal...
  
  Read more

• FDA Investigating Hospitalizations Linked to Counterfeit Ozempic

  09-11-2023 00:57 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of semaglutide.At least one of these reports includes mention of a counterfeit...
  
  Read more

• Double-Lung Transplant, Breast Implants Save Life of Man Who Battled Vaping-Linked Illness

  09-11-2023 00:55 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- "Davey" Bauer hovered on the precipice of death, his lungs damaged by vaping and congested by antibiotic-resistant pneumonia. Doctors saved his life with a jury-rigged artificial lung, a prompt double-lung transplant …...
  
  Read more

• FDA Will Pull Vet Drug Used in Pork Industry Over Cancer Concerns for Humans

  09-11-2023 00:52 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- The U.S. Food and Drug Administration said Tuesday that it plans to pull a veterinary drug used commonly in the pork industry because it might pose a cancer risk to humans who eat pig products.The antimicrobial, carbadox...
  
  Read more

• New Postpartum Depression Drug Comes With Hefty Price Tag

  09-11-2023 00:50 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients will not be able to afford the medication.Zurzuvae (zuranolone)...
  
  Read more

• Zurzuvae for Postpartum Depression Comes With High Cost

  09-11-2023 00:11 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023 -- A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients will not be able to afford the medication.
  Zurzuvae (zuranolone)...
  
  Read more

• 2021 to 2022 Saw 5 Percent Decline in Overall Fetal Mortality Rate

  08-11-2023 17:59 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- The overall U.S. fetal mortality rate decreased by 5 percent between 2021 and 2022, according to a November Vital Statistics Rapid Release report, a publication from the U.S. Centers for Disease Control and...
  
  Read more

• Genetic Predisposition to Insomnia Linked to Insomnia-Like Problems

  08-11-2023 17:57 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- Children who are genetically predisposed to insomnia have more insomnia-like sleep problems from early childhood through adolescence, according to a study published online Nov. 8 in the Journal of Child Psychology and...
  
  Read more

• ASN: eGFR No Different With Sparsentan, Irbesartan in Focal Segmental Glomerulosclerosis

  08-11-2023 17:53 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- No significant differences are seen in the estimated glomerular filtration rate (eGFR) with sparsentan versus irbesartan among patients with focal segmental glomerulosclerosis (FSGS), according to a study published online...
  
  Read more

• ASN: Multicomponent Intervention Does Not Increase Steps Toward Kidney Transplant

  08-11-2023 17:47 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- A multicomponent intervention does not increase the rate of completed steps toward receiving a kidney transplant, according to a study published online Nov. 3 in JAMA Internal Medicine to coincide with Kidney Week, the...
  
  Read more

• AHA: Depression, Anxiety Linked to CVD Risk Factors, MACE

  08-11-2023 17:44 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- Depression and anxiety are associated with an increased risk for cardiovascular disease risk factors (CVDRFs) and major adverse cardiovascular events (MACE), and a higher composite measure of perceived stress is...
  
  Read more

• AHA: High Cardiovascular Health Linked to Lower Phenotypic Age

  08-11-2023 17:41 via drugs.com
  
  WEDNESDAY, Nov. 8, 2023-- There is an inverse association for cardiovascular health (CVH) with phenotypic age (PhenoAge) and phenotypic age acceleration (PhenoAgeAccel), according to a study to be presented at the American Heart Association...
  
  Read more

Follow @PharmaIndustry_ on Twitter!